How to Appeal an HDHP Claim Denial

When a high-deductible health plan denies a claim, enrollees have federally protected rights to challenge that decision through a structured appeal process. This page covers the definition of an HDHP claim appeal, the step-by-step mechanism for filing one, the scenarios in which denials most commonly arise, and the criteria that determine when an appeal is likely to succeed or fail. Understanding these rights is essential because denied claims under an HDHP often carry significant out-of-pocket consequences given the plan's high deductible structure.


Definition and scope

A claim denial appeal is a formal request submitted to a health insurer asking the plan to reverse or modify an adverse benefit determination. Under the Employee Retirement Income Security Act (ERISA) and regulations implementing the Affordable Care Act (ACA), most employer-sponsored and individually purchased health plans — including HDHPs — must maintain an internal appeal process and provide access to an external review process (U.S. Department of Labor, Claims Procedure Regulations, 29 CFR § 2560.503-1).

The scope of the appeal right covers four categories of adverse determinations:

  1. Denial of a claim — the plan refuses payment for a service already rendered.
  2. Denial of prior authorization — the plan refuses to approve a service before it is rendered.
  3. Rescission of coverage — the plan retroactively cancels coverage, affecting claim eligibility.
  4. Reduction or termination of an ongoing course of treatment — the plan stops covering a treatment mid-course.

For HDHP enrollees specifically, the stakes in categories 1 and 2 are amplified because most services must be paid out-of-pocket until the IRS-defined deductible threshold is met. The 2024 IRS minimum deductible for an HDHP is $1,600 for self-only coverage and $3,200 for family coverage (IRS Rev. Proc. 2023-23), which means a single wrongly denied claim can represent a material share of a family's annual health spending. For a broader overview of HDHP mechanics, the HDHP Authority resource index provides structured navigation to related topics.


How it works

The federal appeals process operates in two sequential stages: internal appeal followed by external review.

Stage 1 — Internal Appeal

The enrollee submits a written appeal to the insurer within the timeframe specified in the plan's Summary Plan Description (SPD). For urgent/expedited claims, federal regulation requires a decision within 72 hours. For pre-service claims (prior authorization), the deadline is 30 days. For post-service claims (already-rendered services), the plan has 60 days to issue a decision (29 CFR § 2560.503-1(i)).

The internal appeal package should include:

  1. A copy of the original Explanation of Benefits (EOB) or denial letter, with the denial reason code identified.
  2. A written statement explaining why the denial is incorrect.
  3. Supporting clinical documentation — physician letters, medical records, peer-reviewed literature supporting medical necessity.
  4. The specific plan language or benefit provision the enrollee believes applies.

Stage 2 — External Review

If the internal appeal is upheld, the enrollee may request external review by an Independent Review Organization (IRO). Under ACA § 2719 and the NAIC Uniform External Review Model Act, the IRO's decision is binding on the insurer (CMS, External Appeals). The external review request must typically be filed within 4 months of the final internal denial. IRO reviewers are clinicians with no financial relationship to the insurer.

For state-regulated individual and small-group HDHP plans, state external review laws may provide additional protections — an area addressed in detail at state regulation of HDHP plans.


Common scenarios

Claim denials in HDHPs cluster around a predictable set of fact patterns.

Medical necessity denials are the most frequent category. The insurer asserts that a procedure, imaging study, or specialist visit was not medically necessary under the plan's clinical criteria. These denials are among the most successfully appealed, particularly when the treating physician submits a letter with specific diagnostic justification.

Out-of-network billing disputes arise when an enrollee receives care from a provider outside the plan's network, or when a facility is in-network but an attending physician is not. The No Surprises Act (effective January 1, 2022) (CMS, No Surprises Act) limits balance billing in emergency settings and certain in-patient scenarios, creating a separate dispute resolution pathway that runs parallel to the standard appeal process.

Preventive care classification errors are specific to HDHPs. HDHPs must cover preventive services at zero cost-sharing before the deductible under ACA § 2713, yet billing code errors frequently result in preventive services being processed as diagnostic services subject to the deductible. The 2023 Braidwood Management v. Becerra litigation introduced uncertainty around some preventive mandates; enrollees should verify their plan's specific language when appealing such denials. For a full treatment of what is covered before the deductible, see HDHP preventive care covered before the deductible.

HSA-interaction denials occur when a plan incorrectly applies cost-sharing before the minimum deductible is reached for non-preventive services, which can affect HDHP-qualifying status under 26 U.S.C. § 223.


Decision boundaries

Not every denial is worth appealing, and not every appeal succeeds. The following framework distinguishes situations where an appeal has a strong basis from those where it does not.

Strong appeal basis:

Weak appeal basis:

Internal vs. external review comparison:

Dimension Internal Appeal External Review
Decision-maker Plan's appeal unit Independent Review Organization (IRO)
Timeline (non-urgent) 60 days (post-service) 45 days
Binding on insurer? No — plan can uphold denial Yes — IRO decision is final
Cost to enrollee None (federally mandated) None in most states
Clinical reviewer required? Not always Yes — board-certified clinician

The HDHP consumer protections and appeal rights page provides a broader regulatory context for these procedural rights, including ERISA preemption rules that affect which appeal pathway applies to a given plan type.


References


The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)